Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|March 16, 2013
Author's reply: To PMID 22918966Mauricio Tohen
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 26, 2025
Do patients benefit from collaborations between industry and academia in psychopharmacological research?Mauricio Tohen
Epidemiologia E Psichiatria Sociale|November 21, 2007
Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industryMauricio Tohen
Bipolar Disorders|January 13, 2018
Severity of symptoms in mania-clinical guidelines and study design implicationsMauricio Tohen
Journal of Affective Disorders|June 7, 2016
In memoriam--Vivek SinghMauricio Tohen
The International Journal of Neuropsychopharmacology|September 21, 2017
Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial DesignMauricio Tohen
The Journal of Clinical Psychiatry|December 11, 2012
Methodologies to avoid the enrollment of ineligible patients in clinical trialsMauricio Tohen
The American Journal of Psychiatry|March 11, 2015
Pharmacologic treatments for borderline personality disorderMauricio Tohen
The International Journal of Neuropsychopharmacology|May 16, 2013
Credibility of industry-funded clinical trialsMauricio Tohen
Archives of General Psychiatry|March 5, 2008
Clinical trials in bipolar mania: implications in study design and drug developmentMauricio Tohen
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
The British Journal of Psychiatry : the Journal of Mental Science|March 16, 2013
Author's reply: To PMID 22918966Mauricio Tohen
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 26, 2025
Do patients benefit from collaborations between industry and academia in psychopharmacological research?Mauricio Tohen
Epidemiologia E Psichiatria Sociale|November 21, 2007
Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industryMauricio Tohen
Bipolar Disorders|January 13, 2018
Severity of symptoms in mania-clinical guidelines and study design implicationsMauricio Tohen
Journal of Affective Disorders|June 7, 2016
In memoriam--Vivek SinghMauricio Tohen
The International Journal of Neuropsychopharmacology|September 21, 2017
Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial DesignMauricio Tohen
The Journal of Clinical Psychiatry|December 11, 2012
Methodologies to avoid the enrollment of ineligible patients in clinical trialsMauricio Tohen
The American Journal of Psychiatry|March 11, 2015
Pharmacologic treatments for borderline personality disorderMauricio Tohen
The International Journal of Neuropsychopharmacology|May 16, 2013
Credibility of industry-funded clinical trialsMauricio Tohen
Archives of General Psychiatry|March 5, 2008
Clinical trials in bipolar mania: implications in study design and drug developmentMauricio Tohen
Pageof 26